Abstract: A multi-band electronic apparatus and method thereof is provided. The method comprises outputting a first output signal in the first band by a first voltage controlled oscillator according to a switch control signal and a control voltage, outputting a second output signal in the second band by a second voltage controlled oscillator according to the switch control signal and the control voltage, the second band being not completely overlapped by the first band, performing frequency division selectively on the first output signal or the second frequency divided signal according to the switch control signal, and outputting a first frequency divided signal, determining a phase difference between the first frequency divided signal and a reference signal to output a phase difference signal, outputting the control voltage according to the phase difference signal, and selectively driving the first or the second voltage controlled oscillators by the control voltage according to the switch control signal.

Abstract: The invention concerns an improved therapeutic regimen for the treatment of thrombolytic disorders, such as acute myocardial infarction (AMI). In particular, the present invention concerns the treatment of thrombolytic disorders, e.g., AMI, with a combination of a tissue plasminogen activator (t-PA) variant having improved fibrin specificity and extended plasma half-life when compared with wild-type human t-PA and a low molecular weight heparin.

Abstract: A multi-band electronic apparatus and method thereof is provided. The method comprises outputting a first output signal in the first band by a first voltage controlled oscillator according to a switch control signal and a control voltage, outputting a second output signal in the second band by a second voltage controlled oscillator according to the switch control signal and the control voltage, the second band being not completely overlapped by the first band, performing frequency division selectively on the first output signal or the second frequency divided signal according to the switch control signal, and outputting a first frequency divided signal, determining a phase difference between the first frequency divided signal and a reference signal to output a phase difference signal, outputting the control voltage according to the phase difference signal, and selectively driving the first or the second voltage controlled oscillators by the control voltage according to the switch control signal.

Abstract: The invention concerns an improved therapeutic regimen for the treatment of thrombolytic disorders, such as acute myocardial infarction (AMI). In particular, the present invention concerns the treatment of thrombolytic disorders, e.g., AMI, with a combination of a tissue plasminogen activator (t-PA) variant having improved fibrin specificity and extended plasma half-life when compared with wild-type human t-PA and a low molecular weight heparin.

Abstract: The present invention relates to an adaptive interrupts coalescing system with recognizing minimum delay packets. The adaptive interrupts coalescing system of the invention comprises a first calculating device, a packet header parser, a second calculating device, and an interrupt controller. The first calculating device is used for calculating packet information of a plurality of packets. The packet header parser is used for recognizing the type of service field in each packet and for generating a minimum delay control signal. The second calculating device is used for determining a coalescing interrupt number signal according to the packet information and the minimum delay control signal. The interrupt controller is used for transmitting an interrupt control signal to process the packet according to the coalescing interrupt number signal.

Abstract: A cabinet has a hollow body with an open front, multiple compartments defined within the body, multiple drawers and a duplex extension table received inside the compartment, and multiple optional accessories integrated with the body. Wherein, the duplex extension table is retractable received inside the body via the open front and composed of a primary board and a secondary board retractably combined with each other so as to provide two sectional spaces respectively for laptop and note or documents during working. Moreover, the accessories attached to the body include multiple wheel devices, a socket, a wire-reeling disk and at least one storing container to facilitate the cabinet.

Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.

Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.

Abstract: The invention relates to a method of treating fibromyalgia and other disorders in a mammal by administering a compound compound of Formula I R1 is straight or branched unsubstituted alkyl of from 1 to 5 carbon atoms, unsubstituted phenyl, or unsubstituted cycloalkyl of from 3 to 6 carbon atoms; R2 is hydrogen or methyl; and R3 is hydrogen, methyl, or carboxyl, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.

Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.

Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.

Abstract: The present invention relates to an adaptive interrupts coalescing system with recognizing minimum delay packets. The adaptive interrupts coalescing system of the invention comprises a first calculating device, a packet header parser, a second calculating device, and an interrupt controller. The first calculating device is used for calculating packet information of a plurality of packets. The packet header parser is used for recognizing the type of service field in each packet and for generating a minimum delay control signal. The second calculating device is used for determining a coalescing interrupt number signal according to the packet information and the minimum delay control signal. The interrupt controller is used for transmitting an interrupt control signal to process the packet according to the coalescing interrupt number signal.

Abstract: The present invention discloses a multi-priority media access control method for a multi-channel slotted ring network. In the slotted ring networks, each node has one tunable transmitter and one fixed receiver for data channels, and is able to inspect slot status on all channels. The header slot format defines the slot priorities on ring networks and limits which packets can be transmitted through the slots. By assigning slot priority based on two thresholds to raise and lower slot priority, multiple priority packets can be transmitted.

Abstract: A cabinet with paper shredding function comprises an installation space for installation of a paper shredder, wherein two opposite support ribs are disposed at both sides of the installation space of a housing of the cabinet, each of the support ribs is formed at either end thereof with a mounting hole, a base board has a plurality of inserting holes that are in alignment with the mounting holes of the two support ribs, such that the base board is mounted on the two support ribs by fixing fasteners in the mounting holes and the supporting ribs, the base board is further formed with a mounting slot for positioning the paper shredder, and after being mounted on the base board, the paper shredder is covered with a cover, and the cover has a slot that is identical to a paper feeding hole of the paper shredder in size.

Abstract: This invention relates to certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.

Abstract: This invention relates to certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.

Abstract: The invention concerns an improved therapeutic regimen for the treatment of thrombolytic disorders, such as acute myocardial infarction (AMI). In particular, the present invention concerns the treatment of thrombolytic disorders, e.g., AMI, with a combination of a tissue plasminogen activator (t-PA) variant having improved fibrin specificity and extended plasma half-life when compared with wild-type human t-PA and a low molecular weight heparin.

Abstract: The invention concerns an improved therapeutic regimen for the treatment of thrombolytic disorders, such as acute myocardial infarction (AMI). In particular, the present invention concerns the treatment of thrombolytic disorders, e.g. AMI, with a combination of a tissue plasminogen activator (t-PA) variant having improved fibrin specificity and extended plasma half-life when compared with wild-type human t-PA and a low molecular weight heparin.

Abstract: This invention relates to certain ?-amino acids that bind to the alpha-2-delta (?2?) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.